Rostami A, Robatjazi M, Dareyni A, Ghorbani A, Ganji O, Siyami M
BMC Med Imaging. 2024; 24(1):345.
PMID: 39707207
PMC: 11660597.
DOI: 10.1186/s12880-024-01528-6.
Ashtari F, Najarzadeh P, Shaygannejad V, Adibi I, Ramezani N, Davanian F
J Res Med Sci. 2024; 29:49.
PMID: 39403229
PMC: 11472874.
DOI: 10.4103/jrms.jrms_703_23.
Fu Y, Gu Z, Cao H, Zuo C, Huang Y, Song Y
Front Neurosci. 2024; 18:1432659.
PMID: 39391755
PMC: 11464490.
DOI: 10.3389/fnins.2024.1432659.
Chisari C, Amato M, Di Sapio A, Foschi M, Iaffaldano P, Inglese M
J Neurol. 2024; 271(10):6801-6810.
PMID: 39190108
PMC: 11446943.
DOI: 10.1007/s00415-024-12621-9.
Alwahsh M, Nimer R, Dahabiyeh L, Hamadneh L, Hasan A, Alejel R
Sci Rep. 2024; 14(1):14806.
PMID: 38926483
PMC: 11208524.
DOI: 10.1038/s41598-024-64490-x.
Pediatric traumatic brain injury and early age multiple sclerosis in Finland: A nationwide register-based cohort study.
Laaksonen J, Ponkilainen V, Kuitunen I, Mottonen J, Mattila V
Brain Behav. 2024; 14(4):e3478.
PMID: 38622897
PMC: 11019240.
DOI: 10.1002/brb3.3478.
Risk Factors for Psychiatric Disorders in Patients with Multiple Sclerosis-A Single-Center Study in the Polish Population.
Mado H, Blachut M, Szczegielniak A, Swierzy K, Zajac M, Kubicka-Baczyk K
Medicina (Kaunas). 2024; 60(3).
PMID: 38541102
PMC: 10972173.
DOI: 10.3390/medicina60030376.
Insights into the interplay between Epstein-Barr virus (EBV) and multiple sclerosis (MS): A state-of-the-art review and implications for vaccine development.
Mohammadzamani M, Kazemzadeh K, Chand S, Thapa S, Ebrahimi N, Yazdan Panah M
Health Sci Rep. 2024; 7(2):e1898.
PMID: 38361801
PMC: 10867693.
DOI: 10.1002/hsr2.1898.
Neuromuscular Electrical Stimulation Does Not Influence Spinal Excitability in Multiple Sclerosis Patients.
Scalia M, Borzuola R, Parrella M, Borriello G, Sica F, Monteleone F
J Clin Med. 2024; 13(3).
PMID: 38337396
PMC: 10856365.
DOI: 10.3390/jcm13030704.
Teenager With Recurrent Ataxia, Ophthalmoplegia, and Encephalopathy Associated With Demyelination: From the National Multiple Sclerosis Society Case Conference Proceedings.
Poisson K, Newsome S, Graves J, Zamvil S, Marcus L
Neurol Neuroimmunol Neuroinflamm. 2024; 11(2):e200193.
PMID: 38181318
PMC: 11078149.
DOI: 10.1212/NXI.0000000000200193.
Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties.
Hu Z, Luo Y, Zhu J, Jiang D, Luo Z, Wu L
Cell Biosci. 2023; 13(1):225.
PMID: 38093352
PMC: 10720200.
DOI: 10.1186/s13578-023-01161-w.
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights.
Sharifa M, Ghosh T, Daher O, Bhusal P, Alaameri Y, Naz J
Cureus. 2023; 15(10):e47058.
PMID: 38022314
PMC: 10644699.
DOI: 10.7759/cureus.47058.
Microglia heterogeneity in health and disease.
Dadwal S, Heneka M
FEBS Open Bio. 2023; 14(2):217-229.
PMID: 37945346
PMC: 10839410.
DOI: 10.1002/2211-5463.13735.
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis.
Petersen-Cherubini C, Murphy S, Xin M, Liu Y, Deffenbaugh J, Jahan I
Eur J Immunol. 2023; 54(1):e2350561.
PMID: 37850588
PMC: 10843518.
DOI: 10.1002/eji.202350561.
Multiple Sclerosis Heritability Estimation on Sardinian Ascertained Extended Families Using Bayesian Liability Threshold Model.
Nova A, Fazia T, Saddi V, Piras M, Bernardinelli L
Genes (Basel). 2023; 14(8).
PMID: 37628630
PMC: 10454167.
DOI: 10.3390/genes14081579.
Higher Dietary Acid Load Might Be a Potent Derivative Factor for Multiple Sclerosis: The Results from a Case-Control Study.
Saeedirad Z, Ariyanfar S, Noormohammadi M, Ghorbani Z, Naser Moghadasi A, Shahemi S
Nutrients. 2023; 15(15).
PMID: 37571248
PMC: 10420939.
DOI: 10.3390/nu15153311.
Fingolimod-Associated Macular Edema in the Treatment of Multiple Sclerosis.
Khan A, Gutlapalli S, Sohail M, Patel P, Midha S, Shukla S
Cureus. 2023; 15(7):e41520.
PMID: 37551255
PMC: 10404465.
DOI: 10.7759/cureus.41520.
Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum.
Ortiz G, Torres-Mendoza B, Ramirez-Jirano J, Marquez-Pedroza J, Hernandez-Cruz J, Mireles-Ramirez M
Genes (Basel). 2023; 14(7).
PMID: 37510224
PMC: 10379341.
DOI: 10.3390/genes14071319.
Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary-progressive and relapsing-remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases.
Prajjwal P, Marsool M, Asharaf S, Inban P, Gadam S, Yadav R
Health Sci Rep. 2023; 6(7):e1422.
PMID: 37448727
PMC: 10337274.
DOI: 10.1002/hsr2.1422.
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives.
Villani R, Serviddio G, Avolio C, Cassano T, DAmico E
Clin Exp Med. 2023; 23(7):3321-3338.
PMID: 37421590
PMC: 10618321.
DOI: 10.1007/s10238-023-01128-8.